MediciNova Inc (MNOV)
1.87
-0.12
(-6.03%)
USD |
NASDAQ |
Nov 14, 13:09
MediciNova Net Income (Quarterly): -2.628M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -2.628M |
| March 31, 2024 | -2.754M |
| December 31, 2023 | -2.059M |
| September 30, 2023 | -0.7231M |
| June 30, 2023 | -2.872M |
| March 31, 2023 | -2.918M |
| December 31, 2022 | -3.002M |
| September 30, 2022 | -3.652M |
| June 30, 2022 | -4.029M |
| March 31, 2022 | -3.386M |
| December 31, 2021 | -2.083M |
| September 30, 2021 | -3.579M |
| June 30, 2021 | -4.284M |
| March 31, 2021 | -0.1878M |
| December 31, 2020 | -2.985M |
| September 30, 2020 | -3.704M |
| June 30, 2020 | -4.451M |
| March 31, 2020 | -2.714M |
| December 31, 2019 | -1.984M |
| September 30, 2019 | -2.378M |
| June 30, 2019 | -3.882M |
| March 31, 2019 | -4.697M |
| December 31, 2018 | -0.2079M |
| September 30, 2018 | -6.78M |
| June 30, 2018 | -3.144M |
| Date | Value |
|---|---|
| March 31, 2018 | -4.543M |
| December 31, 2017 | -1.603M |
| September 30, 2017 | -3.755M |
| June 30, 2017 | -2.789M |
| March 31, 2017 | -3.016M |
| December 31, 2016 | -1.449M |
| September 30, 2016 | -2.836M |
| June 30, 2016 | -3.199M |
| March 31, 2016 | -3.382M |
| December 31, 2015 | -2.735M |
| September 30, 2015 | -1.608M |
| June 30, 2015 | -2.287M |
| March 31, 2015 | -2.215M |
| December 31, 2014 | -2.381M |
| September 30, 2014 | -2.340M |
| June 30, 2014 | -2.122M |
| March 31, 2014 | -2.352M |
| December 31, 2013 | 3.413M |
| September 30, 2013 | -2.237M |
| June 30, 2013 | -2.786M |
| March 31, 2013 | -2.419M |
| December 31, 2012 | -2.434M |
| September 30, 2012 | -2.379M |
| June 30, 2012 | -2.281M |
| March 31, 2012 | -3.867M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-4.451M
Minimum
Jun 2020
-0.1878M
Maximum
Mar 2021
-2.842M
Average
-2.918M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
| BioVie Inc | -4.941M |
| BridgeBio Pharma Inc | -73.46M |
| NovaBay Pharmaceuticals Inc | -1.585M |
| Palatin Technologies Inc | -8.250M |
| iBio Inc | -7.778M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.046M |
| EPS Diluted (Quarterly) | -0.05 |
| Enterprise Value | 53.26M |
| Earnings Yield | -8.56% |
| Normalized Earnings Yield | -10.16 |